beta-lactams has been researched along with Burns in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 7 (70.00) | 24.3611 |
2020's | 2 (20.00) | 2.80 |
Authors | Studies |
---|---|
Adams, W; Baldea, A; Bouchard, C; de Bustros, P; Joyce, C; Sanford, A | 1 |
Alshaer, M; Burch, G; Carson, J; Drabick, Z; Mazirka, P; Peloquin, C | 1 |
Dash, S; Gupta, K | 1 |
Azimi, L; Rastegar Lari, A | 1 |
Arnould, JF; Bouquié, R; Dailly, E; Deslandes, G; Fraissinet, F; Jolliet, P; Le Floch, R; Letard de la Bouralière, MA; Naux, E | 1 |
Bahador, A; Esmaeili, D; Jalalvand, N; Kholdi, S; Nasrolahei, M; Saghi, H; Zahedi, B | 1 |
Adabi, M; Gholami, A; Majidpour, َ; Rasouli-Kouhi, S; Talebi-Taher, M | 1 |
Briscoe, SE; Lipman, J; McWhinney, BC; Muller, MJ; Paratz, J; Patel, BM; Paterson, D; Roberts, JA; Rudd, M; See, NC; Ungerer, J | 1 |
Economou, CJ; Jamal, JA; Lipman, J; Roberts, JA | 1 |
Cross, SE; Dalley, AJ; Lipman, J; Roberts, MS; Rudd, M; Venkatesh, B | 1 |
1 review(s) available for beta-lactams and Burns
Article | Year |
---|---|
Improving antibiotic dosing in special situations in the ICU: burns, renal replacement therapy and extracorporeal membrane oxygenation.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Burns; Critical Illness; Drug Resistance, Multiple, Bacterial; Extracorporeal Membrane Oxygenation; Glycoproteins; Humans; Intensive Care Units; Renal Replacement Therapy | 2012 |
9 other study(ies) available for beta-lactams and Burns
Article | Year |
---|---|
Review of culprit drugs associated with patients admitted to the burn unit with the diagnosis of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Syndrome.
Topics: Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; beta-Lactams; Burn Units; Burns; Humans; Retrospective Studies; Stevens-Johnson Syndrome; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Experience with Implementing a Beta-lactam Therapeutic Drug Monitoring Service in a Burn Intensive Care Unit: A Retrospective Chart Review.
Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Burns; Critical Illness; Drug Monitoring; Humans; Intensive Care Units; Retrospective Studies | 2023 |
Efficacy of newer β lactams/ β lactamase inhibitors for treatment of multidrug resistant gram negative infections in burn patients.
Topics: Acinetobacter baumannii; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactams; Burns; Carbapenem-Resistant Enterobacteriaceae; Cephalosporins; Drug Combinations; Drug Development; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Pseudomonas aeruginosa | 2019 |
Collateral sensitivity between aminoglycosides and beta-lactam antibiotics depends on active proton pumps.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactams; Burns; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Genes, Bacterial; Genes, MDR; Gentamicins; Humans; Imipenem; Iran; Membrane Transport Proteins; Microbial Sensitivity Tests; Polymerase Chain Reaction; Proton Pumps; Pseudomonas aeruginosa; Pseudomonas Infections | 2017 |
Pharmacokinetics of ertapenem in burns patients.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Burns; Ertapenem; Humans; Male; Middle Aged; Models, Statistical; Plasma; Prospective Studies; Young Adult | 2013 |
Distribution of bla(OXA-23), ISAba , Aminoglycosides resistant genes among burned & ICU patients in Tehran and Sari, Iran.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Burns; Critical Illness; Cross Infection; DNA Transposable Elements; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Intensive Care Units; Iran; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2014 |
Role of efflux pump inhibitor in decreasing antibiotic cross-resistance of Pseudomonas aeruginosa in a burn hospital in Iran.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Biological Transport, Active; Burns; Drug Resistance, Bacterial; Fluoroquinolones; Genes, Bacterial; Hospitals; Humans; Iran; Microbial Sensitivity Tests; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections | 2016 |
Therapeutic drug monitoring of beta-lactam antibiotics in burns patients--a one-year prospective study.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Body Surface Area; Burns; Creatinine; Drug Monitoring; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Time Factors | 2012 |
Inadequate antimicrobial prophylaxis during surgery: a study of beta-lactam levels during burn debridement.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; beta-Lactams; Burns; Cephalothin; Debridement; Drug Administration Schedule; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Tazobactam | 2007 |